Back to Search
Start Over
Merck announces new real-world data support long-term efficacy and safety profile of Mavenclad
- Source :
- PharmaBiz. September 13, 2019
- Publication Year :
- 2019
-
Abstract
- Merck, a leading science and technology company, announced the presentation of new data for Mavenclad (cladribine tablets), which further characterise the long-term efficacy and safety profile. These data are being [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.599311394